MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer that lacks ER/PR and HER2 receptors. Hence, there is urgency in developing new or novel therapeutic strategies for treatment of TNBC. Our study shows that the Monocyte Chemoattractant Protein-1 (MCP-1) is a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast Cancer Res Treat
Hauptverfasser: Dutta, Pranabananda, Sarkissyan, Marianna, Paico, Kimberly, Wu, Yanyuan, Vadgama, Jaydutt V.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer US 2018
Schlagworte:
Preclinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022526/
https://ncbi.nlm.nih.gov/pubmed/29594759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4760-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge